Quality Of Life In Colorectal Cancer Survivors

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07427901

Enrollment

368

Registered

2026-02-23

Start date

2023-05-01

Completion date

2027-12-31

Last updated

2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Colorectal Cancer, Rectal Cancer

Keywords

Quality of Life, Cancer Survivors, Late Adverse Effects

Brief summary

The purpose of this study is to identify late adverse effects in colorectal cancer patients that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study aims to assess quality of life in colorectal cancer survivors in relation to psycho-physical-social well-being at different time points and to evaluate the prevalence of late adverse effects and their association with diagnosis and specific oncological treatment.

Detailed description

The purpose of this study is to identify late adverse effects in patients with colorectal cancer that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study will assess quality of life in colorectal cancer patients in relation to psycho-physical-social well-being at different time points. In addition, the study will identify and evaluate the prevalence of late adverse effects and analyze their association with diagnosis and specific oncological treatment.

Interventions

OTHERQuality of Life Assessment

Quality of life assessment using questionnaires at 6, 12, and 24 months after oncological treatment.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Intervention model description

Single-group study evaluating quality of life and late adverse effects in colorectal cancer patients at 6, 12, and 24 months after oncological treatment.

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with colorectal cancer (colon or rectal cancer) * Age 25 to 65 years * First oncological treatment performed at the Institute of Oncology Ljubljana * Working-capable patients * Ability to complete questionnaires * Ability to provide written informed consent

Exclusion criteria

* Age \< 25 years or \> 65 years * Patients unable to complete questionnaires * Patients unable to participate in follow-up assessments * Patients who do not provide written informed consent

Design outcomes

Primary

Measure	Time frame	Description
Quality of Life Score (EORTC QLQ-C30 Global Health Status/QoL Scale)	6, 12, and 24 months after oncological treatment	Quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), specifically the Global Health Status/Quality of Life scale (items 29 and 30). Scores will be linearly transformed to a 0 to 100 scale. Higher scores indicate better quality of life.

Secondary

Measure	Time frame	Description
Colorectal Cancer-Specific Quality of Life (EORTC QLQ-CR29)	6, 12, and 24 months after oncological treatment	Colorectal cancer-specific quality of life will be assessed using the EORTC QLQ-CR29 questionnaire. Scores will be linearly transformed to a 0 to 100 scale. Higher scores indicate better functioning for functional scales and worse symptoms for symptom scales.

Countries

Slovenia

Contacts

CONTACTKlavdija Korošec

kkorosec@onko-i.si+386 31630065

CONTACTNeža Gros

ngros@onko-i.si

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026